Cyclopentolate hydrochloride is a short-acting muscarinic antagonist primarily used in ophthalmology to induce mydriasis and cycloplegia for pediatric eye examinations. By effectively blocking acetylcholine… Read more
Cyclopentolate hydrochloride is a short-acting muscarinic antagonist primarily used in ophthalmology to induce mydriasis and cycloplegia for pediatric eye examinations. By effectively blocking acetylcholine receptors within the ocular muscle, it prevents accommodation and facilitates pupil dilation. This category provides essential pharmaceutical reference standards for cyclopentolate hydrochloride, encompassing the active pharmaceutical ingredient, its known impurities, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical procedures, including impurity profiling, method validation, and routine quality control testing. Accessing accurately characterized reference materials, such as N-oxide and nitroso derivatives, ensures precise quantification and regulatory compliance when assessing the stability and safety of ophthalmic formulations. These standards are indispensable for maintaining rigorous analytical accuracy throughout the drug development and manufacturing lifecycle.
